NAATP's CEO-to-CEO (C2C) Meetings are an exclusive opportunity for NAATP Provider Member chief executives to engage in a high-level, peer-to-peer discussion on the challenges and opportunities facing treatment leadership today. 

Topic: AI in Treatment – What Leaders Are Seeing and Doing

Artificial intelligence (AI) is moving quickly and making its way into many aspects of behavioral health from marketing to client intakes, assessments, documentation, and even clinical decision-support. In this CEO-to-CEO session, leaders will connect in an open forum to share how they are currently using (or considering using) AI, what benefits and challenges they are seeing, and how evolving regulations may shape adoption. The emphasis will be on peer exchange — hearing directly from CEOs about the strategies they are embracing, the risks they are weighing, and the opportunities they see ahead.

Eligibility: Attendance is limited to chief executives (CEOs, Executive Directors, Presidents, Founders, and Owners) of organizations that are current NAATP Provider Members.

This session is included in NAATP membership benefits at no additional cost. If you are not currently an NAATP member but wish to participate, we invite you to learn more about membership and apply today.